0.08%

Gold vs US Dollar

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Home
Investing
Stocks
USA
NYSE
Procter and Gamble Co (PG)
Procter and Gamble Co (PG) News

PG Procter and Gamble Co

165.76

1.32 (0.80%)

08 May 2024 - Closed

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type
Procter and Gamble Co	NYSE:PG	NYSE	Common Stock

	Price Change	% Change	Share Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	1.32	0.80%	165.76	166.04	164.59	164.90	6,433,117	01:00:00

Form 144 - Report of proposed sale of securities

29/02/2024 5:55pm

Edgar (US Regulatory)

="/Images/box-unchecked.jpg" alt="Checkbox not checked">326203/01/2022NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller

Title of Securities Sold

Date of Sale

Amount of Securities Sold

Gross Proceeds

R. Alexandra Keith
One Procter & Gamble Plaza
Cincinnati � OH � 45202

Common Stock

11/30/2023

1408

216085.76

R. Alexandra Keith
One Procter & Gamble Plaza
Cincinnati � OH � 45202

Common Stock

11/30/2023

5167

792979.49

144: Remarks and Signature

Remarks

1) Aggregate market value based on average high and low price for February 28, 2024.

Date of Notice

02/29/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Aaron B. Shepherd , attorney-in-fact for R. Alexandra Keith